Self-managed Medication Abortion in the United States.

IF 1.4 4区医学 Q3 OBSTETRICS & GYNECOLOGY

Clinical obstetrics and gynecology Pub Date : 2023-12-01 Epub Date: 2023-09-18 DOI:10.1097/GRF.0000000000000810

Christina Jung, Siripanth Nippita

引用次数: 0

Abstract

Self-managed abortion (SMA) is ending a pregnancy without medical supervision, either by obtaining medications (known as self-managed medication abortion) or through other means. Many factors influence a person's decision to pursue self-managed abortion, such as time constraints, financial considerations, and local availability of abortion services. We present on the prevalence, methods and best practices for clinicians in the United States who may interface with individuals undergoing self-managed medication abortion at any point in the process through a harm reduction approach.

查看原文本刊更多论文

美国自行管理药物流产。

自我管理流产（SMA）是指在没有医疗监督的情况下，通过获得药物（称为自我管理药物流产）或其他方式结束妊娠。许多因素会影响一个人进行自我管理堕胎的决定，如时间限制、经济考虑和当地堕胎服务的可用性。我们介绍了美国临床医生的患病率、方法和最佳实践，他们可以通过减少伤害的方法在堕胎过程中的任何时候与进行自我管理药物流产的个人接触。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical obstetrics and gynecology 医学-妇产科学

CiteScore

2.70

自引率

0.00%

发文量

186

审稿时长

3 months

期刊介绍： Each issue of Clinical Obstetrics and Gynecology is a complete symposium on one or two timely topics of interest in obstetrics and gynecology. For each quarterly issue, two prominent guest editors solicit contributions on key clinical topics of interest to practicing physicians. Procedures, current clinical problems, medical and surgical treatments, and effective diagnostic aids are all carefully reviewed in original articles. The result is an instructive resource that dispenses trustworthy clinical guidance that enhances your understanding of key areas of your practice.